Biolife Solutions (BLFS) Operating Expenses (2010 - 2026)

Biolife Solutions (BLFS) has reported Operating Expenses for 17 consecutive years, with $16.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses fell 47.1% year-over-year to $16.6 million in Q2 2026; TTM through Jun 2026 was $45.6 million, a 22.1% decrease from a year earlier, with the FY2025 full-year figure at $78.7 million, up 44.25% from the prior year.
• Operating Expenses was $16.6 million for Q2 2026 at Biolife Solutions, down from $17.5 million in the prior quarter.
• Over five years, Operating Expenses peaked at $117.1 million in Q2 2022 and troughed at -$131.6 million in Q4 2022.
• A 5-year average of $16.7 million and a median of $21.8 million in 2024 frame the typical range for Operating Expenses.
• The widest YoY moves for Operating Expenses: up 227.46% in 2022, down 335.98% in 2022.
• Over 5 years, Operating Expenses stood at -$131.6 million in 2022, then surged by 55.77% to -$58.2 million in 2023, then surged by 82.84% to -$10.0 million in 2024, then tumbled by 66.83% to -$16.7 million in 2025, then surged by 199.6% to $16.6 million in 2026.
• The last three Operating Expenses figures came in at $16.6 million (Q2 2026), $17.5 million (Q1 2026), and -$16.7 million (Q4 2025), per Business Quant data.